Transient coagulation abnormalities after incompatible blood transfusion.

Unusual response to ABO incompatible blood transfusion.

Thrombotic thrombocytopenic purpura secondary to ABO group incompatible blood transfusion.

Thrombotic thrombocytopenic purpura secondary to ABO group incompatible blood transfusion in a patient after cardiac surgery.

Carrion's disease after blood transfusion.

Coagulation abnormalities and ivermectin.

Eculizumab inhibits hemolysis in a model of ABO-incompatible red blood cell transfusion.

Incompatible blood transfusion: Challenging yet lifesaving in the management of acute severe autoimmune hemolytic anemia.

In vivo Adsorption of Isoagglutinins with Incompatible Red Blood Cell Transfusion in Stem Cell Transplant Recipients.

Reversible cerebral vasoconstriction syndrome after blood transfusion.

Transfusion Support for ABO-Incompatible Progenitor Cell Transplantation.

Integrated coagulation consultation for transfusion medicine.

Antithrombin-III transfusion in disseminated intravascular coagulation.

Antithrombin-III transfusion in disseminated intravascular coagulation.

Thromboelastometry-guided blood transfusion in septic shock complicated with disseminated intravascular coagulation: a case report.

Coagulation defects associated with massive blood transfusion: A large multicenter study.

Management of coagulation abnormalities in liver disease.

Coagulation abnormalities in chronic peritoneal dialysis.

Blood Transfusion.

Hemostasis, coagulation abnormalities, and liver disease.

Coagulation abnormalities in malignancy: a review.

Blood coagulation abnormalities during adoptive immunotherapy with interleukin-2 (r-Met Hu IL-2 [ala 125]).

ABO blood group influences transfusion and survival after cardiac surgery.

Hypertension, convulsions, and purpuric skin lesions after blood-transfusion.

Immunologic changes after blood transfusion in patients undergoing vascular surgery.

Suggest Documents

Unusual response to ABO incompatible blood transfusion.

Thrombotic thrombocytopenic purpura secondary to ABO group incompatible blood transfusion.

Thrombotic thrombocytopenic purpura secondary to ABO group incompatible blood transfusion in a patient after cardiac surgery.

Carrion's disease after blood transfusion.

Coagulation abnormalities and ivermectin.

Eculizumab inhibits hemolysis in a model of ABO-incompatible red blood cell transfusion.

Incompatible blood transfusion: Challenging yet lifesaving in the management of acute severe autoimmune hemolytic anemia.

In vivo Adsorption of Isoagglutinins with Incompatible Red Blood Cell Transfusion in Stem Cell Transplant Recipients.

Reversible cerebral vasoconstriction syndrome after blood transfusion.

Transfusion Support for ABO-Incompatible Progenitor Cell Transplantation.

Integrated coagulation consultation for transfusion medicine.

Antithrombin-III transfusion in disseminated intravascular coagulation.

Antithrombin-III transfusion in disseminated intravascular coagulation.

Thromboelastometry-guided blood transfusion in septic shock complicated with disseminated intravascular coagulation: a case report.

Coagulation defects associated with massive blood transfusion: A large multicenter study.

Management of coagulation abnormalities in liver disease.

Coagulation abnormalities in chronic peritoneal dialysis.

Blood Transfusion.

Hemostasis, coagulation abnormalities, and liver disease.

Coagulation abnormalities in malignancy: a review.

Blood coagulation abnormalities during adoptive immunotherapy with interleukin-2 (r-Met Hu IL-2 [ala 125]).

ABO blood group influences transfusion and survival after cardiac surgery.

Hypertension, convulsions, and purpuric skin lesions after blood-transfusion.

Immunologic changes after blood transfusion in patients undergoing vascular surgery.

Transient coagulation abnormalities after incompatible blood transfusion.

Recommend Documents

Follow Us